Light Rain Fog/Mist 56°
Tag:

Biotechnology

Business
COVID-19: Moderna Will Double Size Of Vaccine Manufacturing Space COVID-19: Moderna Will Double Size Of Vaccine Manufacturing Space
Covid-19: Moderna Will Double Size Of Vaccine Manufacturing Space With the goal of producing billions of COVID-19 vaccine doses by the end of 2022, Moderna announced that it will be expanding its production facility, located in New England. The biotechnology company, which is currently one of three companies that have been granted emergency use authorization to produce COVID-19 vaccines in the United States (along with Pfizer and Johnson & Johnson), announced that it will be doubling the size of the Moderna Technology Center in Norwood, Massachusetts. According to the company, the expansion includes an increase of the company’s production and lab spac…

SHARE

by Zak Failla
Lifestyle
Endomedix Joins U.S. Army Medical Research Groups For Battlefield Trauma Project Endomedix Joins U.S. Army Medical Research Groups For Battlefield Trauma Project
Endomedix Joins U.S. Army Medical Research Groups For Battlefield Trauma Project Our very own Dr. John Abrahams would like to announce some exciting news. In 2005 Dr. Abrahams, along with one other, founded Endomedix, Inc. The firm was focused on the development of biopolymer chemistry to produce solutions that would form hydrogel devices to use for various indications. Dr. Abrahams currently sits as a member of the Board of Directors and provides valuable insight and guidance; especially related to brain tumor and spine surgery. He delivers experience and expertise from his work with the Brain Tumor Research Foundation. On October 11, 2019, Endomedix, Inc. joined th…

SHARE

Content Partner: Brain & Spine Surgeons of NY
News
Former CFO Of Area Biotech Company Admits Embezzling $1 Million Former CFO Of Area Biotech Company Admits Embezzling $1 Million
Former CFO Of Area Biotech Company Admits Embezzling $1 Million The former CFO of a Connecticut biotech company has admitted to embezzling more than a million dollars from his employer, which receives federal research grants. New Haven resident Thomas Malone, who was the CFO of Artificial Cell Technologies Inc. (ACT), has pleaded guilty to four counts of theft from a program involving federal funds. He has also agreed to pay $1,031,508.07 in restitution. Artificial Cell Technologies is a small biotech company that is currently working on developing better ways to deliver malaria and Respiratory Syncytial Virus vaccines to those in need. In addition to …

SHARE

by Zak Failla